Chantal Pichon is a Full Professor at the University of Orléans and nominated at the Institut Universitaire de France. She leads the Innovative therapies and Nanomedicine research lab at the Center for Molecular Biophysics (CBM, CNRS, Orléans, France). She defended her PhD in Marseille University (France) and performed her Post-Doc training at AFRC in Cambridge (UK). Her research activities are focused on the development of innovative therapies based on nucleic acids therapeutics delivered by non-viral systems. Currently, she is developing projects aiming to identify molecular targets/biomarkers that can be exploited to fight cancer, neurological disorders, and aging. Chantal Pichon has a record of accomplishments of 163 peer-reviewed articles, 12 filled patents, and 25 grants (French and European research grants, industrial and charities grants).
Chantal Pichon is a Full Professor at the University of Orléans and nominated at the Institut Universitaire de France. She leads the Innovative therapies and Nanomedicine research lab at the Center for Molecular Biophysics (CBM, CNRS, Orléans, France). She defended her PhD in Marseille University (France) and performed her Post-Doc training at AFRC in Cambridge (UK). Her research activities are focused on the development of innovative therapies based on nucleic acids therapeutics delivered by non-viral systems. Currently, she is developing projects aiming to identify molecular targets/biomarkers that can be exploited to fight cancer, neurological disorders, and aging. Chantal Pichon has a record of accomplishments of 163 peer-reviewed articles, 12 filled patents, and 25 grants (French and European research grants, industrial and charities grants).